Naproxen
- Product NDC
- 42291-628
- 11-digit product format
- 422910628
- Labeler code
- 42291
- Product ID
- 42291-628_d57e8058-bb78-3aa6-e053-2a95a90a1520
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA075927
- Marketing category
- ANDA
- Marketing start
- 2013-09-26
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-628-18 | 42291062818 | 180 TABLET in 1 BOTTLE (42291-628-18) | 180 tablet | 2019-07-17 | 0000-00-00 | No | No | Current |
| 42291-628-20 | 42291062820 | 20 TABLET in 1 BOTTLE (42291-628-20) | 20 tablet | 2013-09-26 | 0000-00-00 | No | No | Current |
| 42291-628-60 | 42291062860 | 60 TABLET in 1 BOTTLE (42291-628-60) | 60 tablet | 2013-09-26 | 0000-00-00 | No | No | Current |